MFDS — authorised 30 September 1997
- Marketing authorisation holder: CEPHALON
- Status: likely_approved
🇰🇷 Gabitril in South Korea
MFDS authorised Gabitril on 30 September 1997
Marketing authorisation
Gabitril in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Gabitril approved in South Korea?
Yes. MFDS authorised it on 30 September 1997.
Who is the marketing authorisation holder for Gabitril in South Korea?
CEPHALON holds the South Korean marketing authorisation.